Insider Trading May 18, 2026 04:52 PM

Aflac Director Sells Shares Amid Company Updates and Financial Analysis

Analysis of recent insider trading activity alongside Aflac's 2026 earnings performance and operational expansions.

By Derek Hwang AFL

Thomas J. Kenny, a director at Aflac Inc., recently sold shares of the company’s common stock on May 15, 2026. This transaction occurred while the stock was trading near its recent high. Despite this insider activity, Aflac provided updates regarding its first-quarter 2026 earnings and ongoing operational developments, including a new facility for state leave administration.

Aflac Director Sells Shares Amid Company Updates and Financial Analysis
AFL

Key Points

  • <li style="margin-bottom: 10px;"><strong>Insiders Activity:</strong> Director Thomas J. Kenny sold 1,740 shares of AFL on May 15, 2026, at $116.57 per share.</li>
  • <li style="margin-bottom: 10px;"><strong>Financial Performance:</strong> Aflac exceeded revenue expectations in Q1 2026 with $4.35 billion, though adjusted EPS ($1.75) narrowly missed the forecast of $1.80.</li>
  • <li style="margin-bottom: 10px;"><strong>Operational Growth:</strong> The company is expanding its presence by opening an office in South Portland, Maine, to manage the state's Paid Family and Medical Leave program for a large number of workers and employers.</li>

Director Thomas J. Kenny recently reported the disposal of shares in Aflac Inc.'s common stock on May 15, 2026. The filing detailing this transaction was subsequently made public on May 18, 2026.

During the sale, Mr. Kenny disposed of 1,740 shares of Aflac common stock. These shares were sold at a price of $116.57 per share, resulting in total proceeds of $202,831. This reported transaction took place while the company's stock was trading at $118.67, which is close to its 52-week high mark of $119.32.

Following the sale, records indicate that Mr. Kenny directly retains a holding of 13,219 shares of Aflac common stock.

Company Financial and Valuation Context

The $60.4 billion insurance company has a long history of dividend growth, having raised its dividend for 42 consecutive years. Currently, the stock offers a yield of 2.09%. Based on an InvestingPro analysis, which uses various valuation models, Aflac is trading at a Price-to-Earnings (P/E) ratio of 13.5. This analysis suggests that Aflac may be undervalued relative to its Fair Value, positioning it among stocks worth monitoring.

First Quarter 2026 Performance and Corporate Governance

In separate corporate news, Aflac Inc. released its first-quarter earnings report for 2026. The results showed a mixed performance regarding key metrics. Specifically, the company's adjusted Earnings Per Share (EPS) was $1.75, which represented a slight shortfall compared to the forecast of $1.80. However, in terms of revenue, Aflac significantly beat expectations, reporting $4.35 billion. This figure surpassed the anticipated forecast of $4.18 billion.

Furthermore, during the annual meeting of shareholders, all company proposals received approval from the shareholders. The sole measure that did not pass was a shareholder initiative calling for an independent board chairman. At the meeting, shareholders elected 11 directors to the board and formally ratified the appointment of KPMG LLP to serve as Aflac's independent registered public accounting firm for the fiscal year ending December 31, 2026.

Operational and Strategic Developments

Aflac also announced a new operational expansion. The company plans to open an office in South Portland, Maine. This facility is dedicated to administering the state’s Paid Family and Medical Leave program. Through this center, Aflac will provide necessary claims administration services for both participating employers and over 500,000 eligible workers within Maine. These diverse recent developments underscore Aflac's continued strategic focus and operational initiatives across various sectors.

Risks

  • <li style="margin-bottom: 10px;"><strong>Market Valuation Uncertainty:</strong> The analysis suggests Aflac is undervalued based on its P/E ratio (13.5) compared to Fair Value, but the stock's current trading price ($118.67) remains near its 52-week high ($119.32), suggesting potential valuation pressure or resistance.</li>
  • <li style="margin-bottom: 10px;"><strong>Governance Challenges:</strong> Shareholders rejected a measure seeking an independent board chairman, which could signal ongoing internal governance debates regarding board structure and independence.</li>

More from Insider Trading

TWFG Director Michael Doak Accumulates $638K in Shares Amid Stock Decline Jun 4, 2026 FormFactor Director Sheri Rhodes Offloads $793K in Equity Amid Strong Quarterly Performance Jun 4, 2026 Zoom CEO Eric Yuan Executes $2.64 Million Share Sales Under Pre-Arranged Trading Plan Jun 4, 2026 Enphase Director Richard Mora Offloads Shares Amid Sector Activity Jun 4, 2026 Datadog CRO Sean Walters Disposes of $3.58M in Equity Ahead of Fiscal Cycle Shift Jun 4, 2026